000 01446 a2200445 4500
005 20250513110719.0
264 0 _c19970414
008 199704s 0 0 eng d
022 _a0094-6176
024 7 _a10.1055/s-2007-999042
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarges, H E
245 0 0 _aTherapeutic factor XIII preparations and perspectives for recombinant factor XIII.
_h[electronic resource]
260 _bSeminars in thrombosis and hemostasis
_c1996
300 _a427-36 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aCattle
650 0 4 _aChild
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Contamination
650 0 4 _aFactor XIII
_xgenetics
650 0 4 _aFactor XIII Deficiency
_xdrug therapy
650 0 4 _aGuidelines as Topic
650 0 4 _aGuinea Pigs
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMolecular Sequence Data
650 0 4 _aPlacenta
_xchemistry
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aSafety
650 0 4 _aVirus Diseases
_xprevention & control
650 0 4 _aWorld Health Organization
700 1 _aMetzner, H J
773 0 _tSeminars in thrombosis and hemostasis
_gvol. 22
_gno. 5
_gp. 427-36
856 4 0 _uhttps://doi.org/10.1055/s-2007-999042
_zAvailable from publisher's website
999 _c8981238
_d8981238